The Global Cholinergic Drugs Market is charting a strong growth trajectory through 2031, driven by rising prevalence of neurological disorders, an aging global population, and expanding therapeutic applications in diseases such as Alzheimer’s, myasthenia gravis, glaucoma, overactive bladder, and schizophrenia. These drugs enhance cholinergic activity in the nervous system and are vital in...